1H-吡唑-4-羧酸,3-甲基-1-丙基- | 705269-96-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 1H-吡唑-4-羧酸,3-甲基-1-丙基-
• 中文别名: 3-甲基-1-丙基-1H-吡唑-4-羧酸
• 英文名称: 3-Methyl-1-propyl-1H-pyrazole-4-carboxylic acid
• 英文别名: 3-methyl-1-propylpyrazole-4-carboxylic acid
• CAS: 705269-96-1
• 化学式: C₈H₁₂N₂O₂
• mdl: MFCD03194467
• 分子量: 168.19
• InChiKey: VXCAGHJDPUBMKC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  55.1
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 海关编码：
  2933199090

文献信息

• [EN] AMIDE COMPOUNDS, COMPOSITIONS AND APPLICATIONS THEREOF<br/>[FR] COMPOSÉS AMIDES, COMPOSITIONS ET APPLICATIONS DE CEUX-CI
  申请人：ADVINUS THERAPEUTICS LTD

  公开号：WO2013042139A1

  公开（公告）日：2013-03-28

  The present disclosure relates to substituted amide compounds that are inhibitors of Fatty Acid Amide Hydrolase (FAAH), their stereoisomers, tautomers, prodrugs, polymorphs, solvates, pharmaceutically acceptable salts, and pharmaceutical compositions containing them. These compounds are useful in the treatment, prevention, prophylaxis, management, or adjunct treatment of all medical conditions related to inhibition of Fatty Acid Amide Hydrolase (FAAH), such as pain including acute and post operative pain, chronic pain, cancer pain, cancer chemotherapy induced pain, neuropathic pain, nociceptive pain, inflammatory pain, back pain, pain due to disease of various origin such as: diabetic neuropathy, neurotropic viral disease including human immunodeficient virus (HIV), herpes zoster such as post herpetic neuralgia; polyneuropathy, neurotoxicity, mechanical nerve injury, carpal tunnel syndrome, immunologic mechanisms like multiple sclerosis; sleep disorders, anxiety and depression disorders, inflammatory disorders, weight and eating disorders, Parkinson's disease, addiction, spasticity, hypertension or other disorders. The disclosure also relates to the process of preparation of the amide compounds. Formula (1). The present disclosure also relates to methods for the preparation of such compounds, and to pharmaceutical compositions containing them.

  本公开涉及替代酰胺化合物，这些化合物是脂肪酸酰胺水解酶（FAAH）的抑制剂，包括它们的立体异构体、互变异构体、前药、多型体、溶剂合物、药用盐以及含有它们的药物组合物。这些化合物在治疗、预防、预防、管理或辅助治疗与脂肪酸酰胺水解酶（FAAH）抑制相关的所有医疗状况中非常有用，例如疼痛，包括急性和术后疼痛，慢性疼痛，癌症疼痛，癌症化疗引起的疼痛，神经痛，伤害性疼痛，炎症性疼痛，背部疼痛，疾病引起的疼痛，如糖尿病性神经病变，神经病毒性疾病，包括人类免疫缺陷病毒（HIV），带状疱疹，如带状疱疹后神经痛；多发性神经病，神经毒性，机械神经损伤，腕管综合症，类似多发性硬化的免疫机制；睡眠障碍，焦虑和抑郁症，炎症性疾病，体重和进食障碍，帕金森病，成瘾，痉挛，高血压或其他疾病。该公开还涉及酰胺化合物的制备过程。公式（1）。本公开还涉及制备这类化合物的方法，以及含有它们的药物组合物。
• Hetero functional binding systems
  申请人：Anteo Technologies Pty Ltd

  公开号：US10768176B2

  公开（公告）日：2020-09-08

  The present invention relates to reagents and methods for binding compounds to surfaces that are hydrophobic. More specifically, the invention relates to simple methods for coating of hydrophobic planar, membrane or particle surfaces to facilitate binding of molecules such as labels, dyes, synthetic and biological polymers and/or nanoparticles thereto.

  本发明涉及将化合物与疏水性表面结合的试剂和方法。更具体地说，本发明涉及涂覆疏水性平面、膜或颗粒表面以促进标签、染料、合成和生物聚合物和/或纳米颗粒等分子与之结合的简单方法。
• AMIDE COMPOUNDS, COMPOSITIONS AND APPLICATIONS THEREOF
  申请人：Advinus Therapeutics Limited

  公开号：EP2758375A1

  公开（公告）日：2014-07-30
• HETERO FUNCTIONAL BINDING SYSTEMS
  申请人：Anteo Technologies Pty Ltd.

  公开号：EP3157938A1

  公开（公告）日：2017-04-26
• [EN] HETERO FUNCTIONAL BINDING SYSTEMS<br/>[FR] SYSTÈMES DE LIAISON HÉTÉROFONCTIONNELS
  申请人：ANTEO TECHNOLOGIES PTY LTD

  公开号：WO2015192183A1

  公开（公告）日：2015-12-23

  The present invention relates to reagents and methods for binding compounds to surfaces that are hydrophobic. More specifically, the invention relates to simple methods for coating of hydrophobic planar, membrane or particle surfaces to facilitate binding of molecules such as labels, dyes, synthetic and biological polymers and/or nanoparticles thereto.